| Bioactivity | Mc-Val-Cit-PAB-Gefitinib chloride is a agent-linker conjugates for ADC. Mc-Val-Cit-PAB-Gefitinib chloride consists of Gefitinib (HY-50895) (an EGFR tyrosine kinase inhibitor) and the ADC linker Mc-Val-Cit-PAB[1]. |
| Name | Mc-Val-Cit-PAB-Gefitinib chloride |
| Formula | C50H63Cl2FN10O9 |
| Molar Mass | 1038.00 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. FLYGARE, John A, et al. Quaternary amine compounds and antibody-drug conjugates thereof. WO2016090050A1. |
Mc-Val-Cit-PAB-Gefitinib chloride
CAS: F: C50H63Cl2FN10O9 W: 1038.00
Mc-Val-Cit-PAB-Gefitinib chloride is a agent-linker conjugates for ADC. Mc-Val-Cit-PAB-Gefitinib chloride consists of Ge
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.